New Tampa Health, Inc.

Tampa, Florida 33603

0 studies enrolling now · 3 studies all time

What they study most

Respiratory Syncytial Virus, Seasonal Influenza

Studies at this site

• A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age — Completed
• Study of mRNA-1010 Seasonal Influenza Vaccine in Adults — Completed
• A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older — Completed